Several new biomarkers can enhance the detection of RA-ILD, including matrix metalloproteinase, surfactant protein D, and pulmonary and activation-regulated chemokine [91], which may be promising for the development of new predictors in future research. Here, SFTPD is linked to interstitial lung disease.